[go: up one dir, main page]

GB202405997D0 - Novel compositions - Google Patents

Novel compositions

Info

Publication number
GB202405997D0
GB202405997D0 GBGB2405997.4A GB202405997A GB202405997D0 GB 202405997 D0 GB202405997 D0 GB 202405997D0 GB 202405997 A GB202405997 A GB 202405997A GB 202405997 D0 GB202405997 D0 GB 202405997D0
Authority
GB
United Kingdom
Prior art keywords
novel compositions
compositions
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2405997.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HELM PHARMACEUTICALS GmbH
Original Assignee
Arecor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arecor Ltd filed Critical Arecor Ltd
Priority to GBGB2405997.4A priority Critical patent/GB202405997D0/en
Publication of GB202405997D0 publication Critical patent/GB202405997D0/en
Priority to PCT/EP2025/061742 priority patent/WO2025229006A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
GBGB2405997.4A 2024-04-29 2024-04-29 Novel compositions Ceased GB202405997D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2405997.4A GB202405997D0 (en) 2024-04-29 2024-04-29 Novel compositions
PCT/EP2025/061742 WO2025229006A1 (en) 2024-04-29 2025-04-29 Compositions comprising dalbavancin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2405997.4A GB202405997D0 (en) 2024-04-29 2024-04-29 Novel compositions

Publications (1)

Publication Number Publication Date
GB202405997D0 true GB202405997D0 (en) 2024-06-12

Family

ID=91375464

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2405997.4A Ceased GB202405997D0 (en) 2024-04-29 2024-04-29 Novel compositions

Country Status (2)

Country Link
GB (1) GB202405997D0 (en)
WO (1) WO2025229006A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
RU2675859C2 (en) 2012-11-29 2018-12-25 Инсмед Инкорпорейтед Stabilised vancomycin formulations
HRP20200101T1 (en) 2014-11-06 2020-04-03 Xellia Pharmaceuticals Aps Glycopeptide compositions
MX2018001571A (en) 2015-08-05 2018-09-06 Childrens Medical Center Compositions with permeation enhancers for drug delivery.
WO2017179003A1 (en) * 2016-04-15 2017-10-19 Lupin Limited Topical compositions for ophthalmic and otic use
RU2019119405A (en) 2016-11-23 2020-12-25 Гуфик Байосайенсиз Лимитед DALBAVANCIN LYOPHILIZED PHARMACEUTICAL COMPOSITIONS
CA3132923A1 (en) 2019-03-08 2020-09-17 Emphascience, Inc. Stable pharmaceutical formulations of peptide and protein drugs
US12343373B2 (en) 2020-10-30 2025-07-01 Somerset Therapeutics, Llc Glycopeptide antibiotics liquid formulations and methods and uses thereof
WO2024079223A1 (en) * 2022-10-12 2024-04-18 Xellia Pharmaceuticals Aps Liquid dalbavancin composition
EP4601616A1 (en) * 2022-10-12 2025-08-20 Hikma Pharmaceuticals USA Inc. Liquid dalbavancin composition

Also Published As

Publication number Publication date
WO2025229006A1 (en) 2025-11-06

Similar Documents

Publication Publication Date Title
GB202415499D0 (en) Novel compositions
GB202405997D0 (en) Novel compositions
GB202405996D0 (en) Novel compositions
GB202511471D0 (en) Exosome-based compositions
GB202510664D0 (en) Compositions
GB202505602D0 (en) Compositions
GB202500743D0 (en) Compositions
GB202411739D0 (en) Compositions
GB202407447D0 (en) Aquafeed compositions
GB202404395D0 (en) Compositions
GB202501526D0 (en) Improved compositions
GB202507755D0 (en) New compositions
GB202504553D0 (en) Novel composition
GB202504551D0 (en) Novel composition
GB202504550D0 (en) Novel composition
GB202415475D0 (en) Novel composition
GB202415070D0 (en) Novel composition
GB202402906D0 (en) Novel composition
GB202316194D0 (en) Novel compositions
GB202217025D0 (en) Novel compositions
GB202510711D0 (en) Composition
GB202509639D0 (en) Composition
GB202508491D0 (en) Composition
GB202508302D0 (en) Transcytosing composition
GB202507920D0 (en) Composition

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: HELM PHARMACEUTICALS GMBH

Free format text: FORMER OWNER: ARECOR LIMITED

AT Applications terminated before publication under section 16(1)